Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:501-507
Published online before print July 19, 2004, doi: 10.1161/01.CIR.0000137116.12176.A6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/5/501    most recent
01.CIR.0000137116.12176.A6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knauth, A. L.
Right arrow Articles by Jenkins, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knauth, A. L.
Right arrow Articles by Jenkins, K. J.
Related Collections
Right arrow Other Treatment

(Circulation. 2004;110:501-507.)
© 2004 American Heart Association, Inc.


Original Articles

Transcatheter Device Closure of Congenital and Postoperative Residual Ventricular Septal Defects

Alison L. Knauth, MD, PhD; James E. Lock, MD; Stanton B. Perry, MD; Doff B. McElhinney, MD; Kimberlee Gauvreau, ScD; Michael J. Landzberg, MD; Jonathan J. Rome, MD; William E. Hellenbrand, MD; Carlos E. Ruiz, MD; Kathy J. Jenkins, MD, MPH

From the Department of Cardiology, Children’s Hospital, Boston, Mass (A.L.K., J.E.L., S.B.P., D.B.M., K.G., M.J.L., K.J.J.); Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pa (J.J.R.); Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY (W.E.H.); and Department of Pediatrics, University of Illinois, Chicago (C.E.R.). Dr Perry is now at Stanford University Medical Center, Stanford, Calif. Dr Ruiz is now at the University of Illinois, Chicago.

Correspondence to Kathy J. Jenkins, MD, MPH, Department of Cardiology, Children’s Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail kathy.jenkins{at}tch.harvard.edu

Received July 1, 2003; de novo received October 22, 2003; revision received April 1, 2004; accepted April 4, 2004.

Background— Our purpose was to describe a 13-year experience with patients undergoing transcatheter device closure of unrepaired congenital or postoperative residual ventricular septal defects (VSDs).

Methods and Results— Since 1989, 170 patients (median age, 3.9 years) have undergone catheterization for closure of 1 or more congenital (n=92) or postoperative (n=78) residual VSDs using successive generations of STARFlex-type devices. Outcomes included echocardiographic assessment of residual flow and device position, assessment of VSD shunt/severity, and adverse events. Among 168 patients in whom device implantation was performed, between 1 and 7 devices were placed per patient (median, 1), with multiple devices placed in 40%. There was a significant decrease in left-to-right shunting after device implantation (P<0.001) and significant improvement in VSD size/severity, and device position proved stable. Of 332 adverse events, 39 were related to the device and 261 were related to the catheterization; all but 5 occurred in the periprocedural period. At a median follow-up of 24 months (0 to 154 months), 14 patients had died and 18 had device(s) explanted.

Conclusions— Congenital and postoperative VSD closure using STARFlex-type devices resulted in stable improvement in clinical status and decreased interventricular shunting. Although periprocedural events occurred frequently, late events caused by the device were rare. Transcatheter device closure is an effective management option for patients with complex muscular VSDs that are difficult to approach surgically and for postoperative residual VSDs.


Key Words: catheterization • heart septal defects • ventricles




This article has been cited by other articles:


Home page
CirculationHome page
P. Khairy and A. J. Marelli
Clinical Use of Electrocardiography in Adults With Congenital Heart Disease
Circulation, December 4, 2007; 116(23): 2734 - 2746.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Carminati, G. Butera, M. Chessa, J. De Giovanni, G. Fisher, M. Gewillig, M. Peuster, J. F. Piechaud, G. Santoro, H. Sievert, et al.
Transcatheter closure of congenital ventricular septal defects: results of the European Registry
Eur. Heart J., October 1, 2007; 28(19): 2361 - 2368.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Butera, M. Carminati, M. Chessa, L. Piazza, A. Micheletti, D. G. Negura, R. Abella, A. Giamberti, and A. Frigiola
Transcatheter Closure of Perimembranous Ventricular Septal Defects: Early and Long-Term Results
J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1189 - 1195.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. P. Walsh
Interventional Electrophysiology in Patients With Congenital Heart Disease
Circulation, June 26, 2007; 115(25): 3224 - 3234.
[Full Text] [PDF]


Home page
CirculationHome page
I. Inglessis and M. J. Landzberg
Interventional Catheterization in Adult Congenital Heart Disease
Circulation, March 27, 2007; 115(12): 1622 - 1633.
[Full Text] [PDF]


Home page
CirculationHome page
E. P. Walsh and F. Cecchin
Arrhythmias in Adult Patients With Congenital Heart Disease
Circulation, January 30, 2007; 115(4): 534 - 545.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
I. A. Russell, K. Rouine-Rapp, G. Stratmann, and W. C. Miller-Hance
Congenital heart disease in the adult: a review with internet-accessible transesophageal echocardiographic images.
Anesth. Analg., March 1, 2006; 102(3): 694 - 723.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. P. Graham Jr
The Year in Congenital Heart Disease
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1887 - 1899.
[Full Text] [PDF]